在蓝色先天性心脏病中冠状动脉微循环
Eduard I Dedkov1, Joseph K Perloff, Robert J Tomanek
1Department of Anatomy and Cell Biology and Cardiovascular Center, University of Iowa Carver College of Medicine, Iowa City, USA.
Circulation
|July 13, 2006
概括
冠状动脉微循环改造可以在阴影性先天性心脏病中保持正常的血液流量储备. 增加的动脉直径弥补了减少的长度密度,保持了至关重要的血流容量.
科学领域:
- 心血管研究研究心血管研究
- 儿童心脏病学 儿童心脏病学
- 血管生物学 血管生物学
背景情况:
- 蓝色先天性心脏病 (CCHD) 呈现为基础冠状动脉血流增加,但正常的流量储备.
- 尽管CCHD的血液动力学发生了变化,但保持流量储备的机制尚未完全理解.
- 假设冠状动脉微循环改造是维持流量储备的关键.
研究的目的:
- 为了研究心血管疾病中冠状动脉微循环的形态特征.
- 为了确定微循环改造是否解释了CCHD中保存的冠状动脉流量储备.
- 为了比较心血管疾病中的微循环适应与心室缩的微循环适应.
主要方法:
- 来自四组尸体解剖心脏样本的形态测量分析:艾森门格综合征 (CCHD),高异常心脏,高正常心脏和正常心脏.
- 冠状动脉小动脉的免疫标记用于光滑肌肉的α-actin.
- 测量动脉尺寸 (轴,面积,周长) 并计算长度,体积和表面密度.
主要成果:
- 在动脉动脉长度密度 (P=0.03) 和直径 (P=0.03) 中观察到显著的跨组差异.
- 患有艾森门格综合征的心脏表现出明显较低的动脉动脉长度密度,但与缩心脏相比,动脉动脉平均直径 (34%) 显著增加 (P=0.03).
- 动脉体积密度在所有组中保持相似.
结论:
- 冠状动脉微循环的重塑是CCHD中保持流量储量的主要机制.
- 动脉动脉直径的增加补偿了动脉动脉长度密度的减少.
- 这种补偿性动脉扩大是维持常规冠状动脉流量储备在CCHD的主要解剖基础.
更多相关视频
相关概念视频
Coronary Circulation
9.9K
The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
9.9K
Physiology of the Heart: The Cardiac Cycle
15.9K
The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
15.9K
Mitral Stenosis I: Introduction
1.8K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805


